Global Neurodegenerative Disease Market Research Report 2025(Status and Outlook)

March 2025 | 246 pages | ID: G477F4492F22EN
Bosson Research

Abstracts

Report Overview

Neurodegenerative diseases are a group of disorders characterized by the progressive degeneration of the structure and function of the nervous system, leading to cognitive and motor impairments. Examples include Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).

This report provides a deep insight into the global Neurodegenerative Disease market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neurodegenerative Disease Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neurodegenerative Disease market in any manner.

Global Neurodegenerative Disease Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Novartis

Pfizer

Merck Serono

Biogen Idec

TEVA

UCB

Boehringer Ingelheim

Sanofi

GlaxoSmithKline

Livzon Pharmaceutical

Haisco Pharmaceutical

Jingxin Pharmaceutical

Dongcheng Biochemicals

Hisun Pharmaceutical

Luye Pharma

Ark Pharmaceutical

Kanghong Pharmaceutical

Huahai Pharmaceutical

BORA PHARMACEUTICALS

Market Segmentation (by Type)

NMDA

SSRIs

Dopamine Inhibitors

Market Segmentation (by Application)

Parkinson’s Disease

Huntington Disease

Amyotrophic Lateral Sclerosis

Alzheimer’s Disease

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Neurodegenerative Disease Market
• Overview of the regional outlook of the Neurodegenerative Disease Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neurodegenerative Disease Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Neurodegenerative Disease
1.2 Key Market Segments
  1.2.1 Neurodegenerative Disease Segment by Type
  1.2.2 Neurodegenerative Disease Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL NEURODEGENERATIVE DISEASE MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Neurodegenerative Disease Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Neurodegenerative Disease Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL NEURODEGENERATIVE DISEASE MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Neurodegenerative Disease Product Life Cycle
3.3 Global Neurodegenerative Disease Sales by Manufacturers (2020-2025)
3.4 Global Neurodegenerative Disease Revenue Market Share by Manufacturers (2020-2025)
3.5 Neurodegenerative Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Neurodegenerative Disease Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Neurodegenerative Disease Manufacturing Sites, Area Served, Product Type
3.8 Neurodegenerative Disease Market Competitive Situation and Trends
  3.8.1 Neurodegenerative Disease Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Neurodegenerative Disease Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 NEURODEGENERATIVE DISEASE INDUSTRY CHAIN ANALYSIS

4.1 Neurodegenerative Disease Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF NEURODEGENERATIVE DISEASE MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Neurodegenerative Disease Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Neurodegenerative Disease Market
5.7 ESG Ratings of Leading Companies

6 GLOBAL NEURODEGENERATIVE DISEASE MARKET BY REGION

6.1 Global Neurodegenerative Disease Market Size by Region
  6.1.1 Global Neurodegenerative Disease Market Size by Region
  6.1.2 Global Neurodegenerative Disease Market Size Market Share by Region
6.2 Global Neurodegenerative Disease Sales by Region
  6.2.1 Global Neurodegenerative Disease Sales by Region
  6.2.2 Global Neurodegenerative Disease Sales Market Share by Region

7 NORTH AMERICA MARKET OVERVIEW

7.1 North America Neurodegenerative Disease Market Size by Country
  7.1.1 USA Market Overview
  7.1.2 Canada Market Overview
  7.1.3 Mexico Market Overview
7.2 North America Neurodegenerative Disease Market Size by Type
7.3 North America Neurodegenerative Disease Market Size by Application

8 EUROPE MARKET OVERVIEW

8.1 Europe Neurodegenerative Disease Market Size by Country
  8.1.1 Germany Market Overview
  8.1.2 France Market Overview
  8.1.3 U.K. Market Overview
  8.1.4 Italy Market Overview
  8.1.5 Spain Market Overview
8.2 Europe Neurodegenerative Disease Market Size by Type
8.3 Europe Neurodegenerative Disease Market Size by Application

9 ASIA-PACIFIC MARKET OVERVIEW

9.1 Asia-Pacific Neurodegenerative Disease Market Size by Country
  9.1.1 China Market Overview
  9.1.2 Japan Market Overview
  9.1.3 South Korea Market Overview
  9.1.4 India Market Overview
  9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Neurodegenerative Disease Market Size by Type
9.3 Asia-Pacific Neurodegenerative Disease Market Size by Application

10 SOUTH AMERICA MARKET OVERVIEW

10.1 South America Neurodegenerative Disease Market Size by Country
  10.1.1 Brazil Market Overview
  10.1.2 Argentina Market Overview
  10.1.3 Columbia Market Overview
10.2 South America Neurodegenerative Disease Market Size by Type
10.3 South America Neurodegenerative Disease Market Size by Application

11 MIDDLE EAST AND AFRICA MARKET OVERVIEW

11.1 Middle East and Africa Neurodegenerative Disease Market Size by Country
  11.1.1 Saudi Arabia Market Overview
  11.1.2 UAE Market Overview
  11.1.3 Egypt Market Overview
  11.1.4 Nigeria Market Overview
  11.1.5 South Africa Market Overview
11.2 Middle East and Africa Neurodegenerative Disease Market Size by Type
11.3 Middle East and Africa Neurodegenerative Disease Market Size by Application

12 NEURODEGENERATIVE DISEASE MARKET PRODUCTION BY REGION

12.1 Global Production of Neurodegenerative Disease by Region(2020-2025)
12.2 Global Neurodegenerative Disease Revenue Market Share by Region (2020-2025)
12.3 Global Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Neurodegenerative Disease Production
  12.4.1 North America Neurodegenerative Disease Production Growth Rate (2020-2025)
  12.4.2 North America Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Neurodegenerative Disease Production
  12.5.1 Europe Neurodegenerative Disease Production Growth Rate (2020-2025)
  12.5.2 Europe Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Neurodegenerative Disease Production (2020-2025)
  12.6.1 Japan Neurodegenerative Disease Production Growth Rate (2020-2025)
  12.6.2 Japan Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Neurodegenerative Disease Production (2020-2025)
  12.7.1 China Neurodegenerative Disease Production Growth Rate (2020-2025)
  12.7.2 China Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2020-2025)

13 NEURODEGENERATIVE DISEASE MARKET SEGMENTATION BY TYPE

13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Neurodegenerative Disease Sales Market Share by Type (2020-2033)
13.3 Global Neurodegenerative Disease Market Size Market Share by Type (2020-2033)
13.4 Global Neurodegenerative Disease Price by Type (2020-2033)

14 NEURODEGENERATIVE DISEASE MARKET SEGMENTATION BY APPLICATION

14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Neurodegenerative Disease Market Sales by Application (2020-2033)
14.3 Global Neurodegenerative Disease Market Size (M USD) by Application (2020-2033)
14.4 Global Neurodegenerative Disease Sales Growth Rate by Application (2020-2033)

15 KEY COMPANIES PROFILE

15.1 Novartis
  15.1.1 Novartis Basic Information
  15.1.2 Novartis Neurodegenerative Disease Product Overview
  15.1.3 Novartis Neurodegenerative Disease Product Market Performance
  15.1.4 Novartis Business Overview
  15.1.5 Novartis SWOT Analysis
  15.1.6 Novartis Recent Developments
15.2 Pfizer
  15.2.1 Pfizer Basic Information
  15.2.2 Pfizer Neurodegenerative Disease Product Overview
  15.2.3 Pfizer Neurodegenerative Disease Product Market Performance
  15.2.4 Pfizer Business Overview
  15.2.5 Pfizer SWOT Analysis
  15.2.6 Pfizer Recent Developments
15.3 Merck Serono
  15.3.1 Merck Serono Basic Information
  15.3.2 Merck Serono Neurodegenerative Disease Product Overview
  15.3.3 Merck Serono Neurodegenerative Disease Product Market Performance
  15.3.4 Merck Serono Business Overview
  15.3.5 Merck Serono SWOT Analysis
  15.3.6 Merck Serono Recent Developments
15.4 Biogen Idec
  15.4.1 Biogen Idec Basic Information
  15.4.2 Biogen Idec Neurodegenerative Disease Product Overview
  15.4.3 Biogen Idec Neurodegenerative Disease Product Market Performance
  15.4.4 Biogen Idec Business Overview
  15.4.5 Biogen Idec Recent Developments
15.5 TEVA
  15.5.1 TEVA Basic Information
  15.5.2 TEVA Neurodegenerative Disease Product Overview
  15.5.3 TEVA Neurodegenerative Disease Product Market Performance
  15.5.4 TEVA Business Overview
  15.5.5 TEVA Recent Developments
15.6 UCB
  15.6.1 UCB Basic Information
  15.6.2 UCB Neurodegenerative Disease Product Overview
  15.6.3 UCB Neurodegenerative Disease Product Market Performance
  15.6.4 UCB Business Overview
  15.6.5 UCB Recent Developments
15.7 Boehringer Ingelheim
  15.7.1 Boehringer Ingelheim Basic Information
  15.7.2 Boehringer Ingelheim Neurodegenerative Disease Product Overview
  15.7.3 Boehringer Ingelheim Neurodegenerative Disease Product Market Performance
  15.7.4 Boehringer Ingelheim Business Overview
  15.7.5 Boehringer Ingelheim Recent Developments
15.8 Sanofi
  15.8.1 Sanofi Basic Information
  15.8.2 Sanofi Neurodegenerative Disease Product Overview
  15.8.3 Sanofi Neurodegenerative Disease Product Market Performance
  15.8.4 Sanofi Business Overview
  15.8.5 Sanofi Recent Developments
15.9 GlaxoSmithKline
  15.9.1 GlaxoSmithKline Basic Information
  15.9.2 GlaxoSmithKline Neurodegenerative Disease Product Overview
  15.9.3 GlaxoSmithKline Neurodegenerative Disease Product Market Performance
  15.9.4 GlaxoSmithKline Business Overview
  15.9.5 GlaxoSmithKline Recent Developments
15.10 Livzon Pharmaceutical
  15.10.1 Livzon Pharmaceutical Basic Information
  15.10.2 Livzon Pharmaceutical Neurodegenerative Disease Product Overview
  15.10.3 Livzon Pharmaceutical Neurodegenerative Disease Product Market Performance
  15.10.4 Livzon Pharmaceutical Business Overview
  15.10.5 Livzon Pharmaceutical Recent Developments
15.11 Haisco Pharmaceutical
  15.11.1 Haisco Pharmaceutical Basic Information
  15.11.2 Haisco Pharmaceutical Neurodegenerative Disease Product Overview
  15.11.3 Haisco Pharmaceutical Neurodegenerative Disease Product Market Performance
  15.11.4 Haisco Pharmaceutical Business Overview
  15.11.5 Haisco Pharmaceutical Recent Developments
15.12 Jingxin Pharmaceutical
  15.12.1 Jingxin Pharmaceutical Basic Information
  15.12.2 Jingxin Pharmaceutical Neurodegenerative Disease Product Overview
  15.12.3 Jingxin Pharmaceutical Neurodegenerative Disease Product Market Performance
  15.12.4 Jingxin Pharmaceutical Business Overview
  15.12.5 Jingxin Pharmaceutical Recent Developments
15.13 Dongcheng Biochemicals
  15.13.1 Dongcheng Biochemicals Basic Information
  15.13.2 Dongcheng Biochemicals Neurodegenerative Disease Product Overview
  15.13.3 Dongcheng Biochemicals Neurodegenerative Disease Product Market Performance
  15.13.4 Dongcheng Biochemicals Business Overview
  15.13.5 Dongcheng Biochemicals Recent Developments
15.14 Hisun Pharmaceutical
  15.14.1 Hisun Pharmaceutical Basic Information
  15.14.2 Hisun Pharmaceutical Neurodegenerative Disease Product Overview
  15.14.3 Hisun Pharmaceutical Neurodegenerative Disease Product Market Performance
  15.14.4 Hisun Pharmaceutical Business Overview
  15.14.5 Hisun Pharmaceutical Recent Developments
15.15 Luye Pharma
  15.15.1 Luye Pharma Basic Information
  15.15.2 Luye Pharma Neurodegenerative Disease Product Overview
  15.15.3 Luye Pharma Neurodegenerative Disease Product Market Performance
  15.15.4 Luye Pharma Business Overview
  15.15.5 Luye Pharma Recent Developments
15.16 Ark Pharmaceutical
  15.16.1 Ark Pharmaceutical Basic Information
  15.16.2 Ark Pharmaceutical Neurodegenerative Disease Product Overview
  15.16.3 Ark Pharmaceutical Neurodegenerative Disease Product Market Performance
  15.16.4 Ark Pharmaceutical Business Overview
  15.16.5 Ark Pharmaceutical Recent Developments
15.17 Kanghong Pharmaceutical
  15.17.1 Kanghong Pharmaceutical Basic Information
  15.17.2 Kanghong Pharmaceutical Neurodegenerative Disease Product Overview
  15.17.3 Kanghong Pharmaceutical Neurodegenerative Disease Product Market Performance
  15.17.4 Kanghong Pharmaceutical Business Overview
  15.17.5 Kanghong Pharmaceutical Recent Developments
15.18 Huahai Pharmaceutical
  15.18.1 Huahai Pharmaceutical Basic Information
  15.18.2 Huahai Pharmaceutical Neurodegenerative Disease Product Overview
  15.18.3 Huahai Pharmaceutical Neurodegenerative Disease Product Market Performance
  15.18.4 Huahai Pharmaceutical Business Overview
  15.18.5 Huahai Pharmaceutical Recent Developments
15.19 BORA PHARMACEUTICALS
  15.19.1 BORA PHARMACEUTICALS Basic Information
  15.19.2 BORA PHARMACEUTICALS Neurodegenerative Disease Product Overview
  15.19.3 BORA PHARMACEUTICALS Neurodegenerative Disease Product Market Performance
  15.19.4 BORA PHARMACEUTICALS Business Overview
  15.19.5 BORA PHARMACEUTICALS Recent Developments

16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Neurodegenerative Disease Market Size by Type (M USD)
Table 4. Global Neurodegenerative Disease Market Size by Application (M USD)
Table 5. Neurodegenerative Disease Market Size Comparison by Region (M USD)
Table 6. Global Neurodegenerative Disease Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Neurodegenerative Disease Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Neurodegenerative Disease Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Neurodegenerative Disease Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurodegenerative Disease as of 2024)
Table 11. Global Market Neurodegenerative Disease Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Neurodegenerative Disease Manufacturing Sites and Area Served
Table 13. Manufacturers Neurodegenerative Disease Product Type
Table 14. Global Neurodegenerative Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neurodegenerative Disease Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Neurodegenerative Disease Market Size Comparison by Region (M USD)
Table 26. Global Neurodegenerative Disease Market Size by Region (2020-2033) & (M USD)
Table 27. Global Neurodegenerative Disease Market Size Market Share by Region (2020-2033)
Table 28. Global Neurodegenerative Disease Sales by Region (2020-2033) & (K MT)
Table 29. Global Neurodegenerative Disease Sales Market Share by Region (2020-2033)
Table 30. North America Neurodegenerative Disease Market Size by Country (2020-2033) & (M USD)
Table 31. North America Neurodegenerative Disease Sales by Country (2020-2033) & (K MT)
Table 32. North America Neurodegenerative Disease Sales by Type (K MT)
Table 33. North America Neurodegenerative Disease Market Size by Type (M USD)
Table 34. North America Neurodegenerative Disease Sales (K MT) by Type (2020-2033)
Table 35. North America Neurodegenerative Disease Market Size (M USD) by Type (2020-2033)
Table 36. North America Neurodegenerative Disease Sales by Application (K MT)
Table 37. North America Neurodegenerative Disease Market Size by Application (M USD)
Table 38. North America Neurodegenerative Disease Sales (K MT) by Application (2020-2033)
Table 39. North America Neurodegenerative Disease Market Size (M USD) by Application (2020-2033)
Table 40. Europe Neurodegenerative Disease Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Neurodegenerative Disease Sales by Country (2020-2033) & (K MT)
Table 42. Europe Neurodegenerative Disease Sales by Type (K MT)
Table 43. Europe Neurodegenerative Disease Market Size by Type (M USD)
Table 44. Europe Neurodegenerative Disease Sales (K MT) by Type (2020-2033)
Table 45. Europe Neurodegenerative Disease Market Size (M USD) by Type (2020-2033)
Table 46. Europe Neurodegenerative Disease Sales by Application (K MT)
Table 47. Europe Neurodegenerative Disease Market Size by Application (M USD)
Table 48. Europe Neurodegenerative Disease Sales (K MT) by Application (2020-2033)
Table 49. Europe Neurodegenerative Disease Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Neurodegenerative Disease Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Neurodegenerative Disease Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Neurodegenerative Disease Sales by Type (K MT)
Table 53. Asia-Pacific Neurodegenerative Disease Market Size by Type (M USD)
Table 54. Asia-Pacific Neurodegenerative Disease Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Neurodegenerative Disease Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Neurodegenerative Disease Sales by Application (K MT)
Table 57. Asia-Pacific Neurodegenerative Disease Market Size by Application (M USD)
Table 58. Asia-Pacific Neurodegenerative Disease Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Neurodegenerative Disease Market Size (M USD) by Application (2020-2025)
Table 60. South America Neurodegenerative Disease Market Size by Country (2020-2033) & (M USD)
Table 61. South America Neurodegenerative Disease Sales by Country (2020-2033) & (K MT)
Table 62. South America Neurodegenerative Disease Sales by Type (K MT)
Table 63. South America Neurodegenerative Disease Market Size by Type (M USD)
Table 64. South America Neurodegenerative Disease Sales (K MT) by Type (2020-2033)
Table 65. South America Neurodegenerative Disease Market Size (M USD) by Type (2020-2033)
Table 66. South America Neurodegenerative Disease Sales by Application (K MT)
Table 67. South America Neurodegenerative Disease Market Size by Application (M USD)
Table 68. South America Neurodegenerative Disease Sales (K MT) by Application (2020-2033)
Table 69. South America Neurodegenerative Disease Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Neurodegenerative Disease Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Neurodegenerative Disease Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Neurodegenerative Disease Sales by Type (K MT)
Table 73. Middle East and Africa Neurodegenerative Disease Market Size by Type (M USD)
Table 74. Middle East and Africa Neurodegenerative Disease Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Neurodegenerative Disease Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Neurodegenerative Disease Sales by Application (K MT)
Table 77. Middle East and Africa Neurodegenerative Disease Market Size by Application (M USD)
Table 78. Middle East and Africa Neurodegenerative Disease Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Neurodegenerative Disease Market Size (M USD) by Application (2020-2033)
Table 80. Global Neurodegenerative Disease Production (K MT) by Region(2020-2025)
Table 81. Global Neurodegenerative Disease Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Neurodegenerative Disease Revenue Market Share by Region (2020-2025)
Table 83. Global Neurodegenerative Disease Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Neurodegenerative Disease Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Neurodegenerative Disease Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Neurodegenerative Disease Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Neurodegenerative Disease Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Neurodegenerative Disease Sales by Type (K MT)
Table 89. Global Neurodegenerative Disease Market Size by Type (M USD)
Table 90. Global Neurodegenerative Disease Sales (K MT) by Type (2020-2033)
Table 91. Global Neurodegenerative Disease Sales Market Share by Type (2020-2033)
Table 92. Global Neurodegenerative Disease Market Size (M USD) by Type (2020-2033)
Table 93. Global Neurodegenerative Disease Market Size Share by Type (2020-2033)
Table 94. Global Neurodegenerative Disease Sales (K MT) by Application
Table 95. Global Neurodegenerative Disease Market Size by Application(M USD)
Table 96. Global Neurodegenerative Disease Sales by Application (2020-2033) & (K MT)
Table 97. Global Neurodegenerative Disease Sales Market Share by Application (2020-2033)
Table 98. Global Neurodegenerative Disease Market Size by Application (2020-2033) & (M USD)
Table 99. Global Neurodegenerative Disease Market Share by Application (2020-2033)
Table 100. Global Neurodegenerative Disease Sales Growth Rate by Application (2020-2033)
Table 101. Novartis Basic Information
Table 102. Novartis Neurodegenerative Disease Product Overview
Table 103. Novartis Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Novartis Business Overview
Table 105. Novartis SWOT Analysis
Table 106. Novartis Recent Developments
Table 107. Pfizer Basic Information
Table 108. Pfizer Neurodegenerative Disease Product Overview
Table 109. Pfizer Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Pfizer Business Overview
Table 111. Pfizer SWOT Analysis
Table 112. Pfizer Recent Developments
Table 113. Merck Serono Basic Information
Table 114. Merck Serono Neurodegenerative Disease Product Overview
Table 115. Merck Serono Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Merck Serono Business Overview
Table 117. Merck Serono SWOT Analysis
Table 118. Merck Serono Recent Developments
Table 119. Biogen Idec Basic Information
Table 120. Biogen Idec Neurodegenerative Disease Product Overview
Table 121. Biogen Idec Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Biogen Idec Business Overview
Table 123. Biogen Idec Recent Developments
Table 124. TEVA Basic Information
Table 125. TEVA Neurodegenerative Disease Product Overview
Table 126. TEVA Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. TEVA Business Overview
Table 128. TEVA Recent Developments
Table 129. UCB Basic Information
Table 130. UCB Neurodegenerative Disease Product Overview
Table 131. UCB Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. UCB Business Overview
Table 133. UCB Recent Developments
Table 134. Boehringer Ingelheim Basic Information
Table 135. Boehringer Ingelheim Neurodegenerative Disease Product Overview
Table 136. Boehringer Ingelheim Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Boehringer Ingelheim Business Overview
Table 138. Boehringer Ingelheim Recent Developments
Table 139. Sanofi Basic Information
Table 140. Sanofi Neurodegenerative Disease Product Overview
Table 141. Sanofi Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Sanofi Business Overview
Table 143. Sanofi Recent Developments
Table 144. GlaxoSmithKline Basic Information
Table 145. GlaxoSmithKline Neurodegenerative Disease Product Overview
Table 146. GlaxoSmithKline Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. GlaxoSmithKline Business Overview
Table 148. GlaxoSmithKline Recent Developments
Table 149. Livzon Pharmaceutical Basic Information
Table 150. Livzon Pharmaceutical Neurodegenerative Disease Product Overview
Table 151. Livzon Pharmaceutical Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Livzon Pharmaceutical Business Overview
Table 153. Livzon Pharmaceutical Recent Developments
Table 154. Haisco Pharmaceutical Basic Information
Table 155. Haisco Pharmaceutical Neurodegenerative Disease Product Overview
Table 156. Haisco Pharmaceutical Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Haisco Pharmaceutical Business Overview
Table 158. Haisco Pharmaceutical Recent Developments
Table 159. Jingxin Pharmaceutical Basic Information
Table 160. Jingxin Pharmaceutical Neurodegenerative Disease Product Overview
Table 161. Jingxin Pharmaceutical Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Jingxin Pharmaceutical Business Overview
Table 163. Jingxin Pharmaceutical Recent Developments
Table 164. Dongcheng Biochemicals Basic Information
Table 165. Dongcheng Biochemicals Neurodegenerative Disease Product Overview
Table 166. Dongcheng Biochemicals Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Dongcheng Biochemicals Business Overview
Table 168. Dongcheng Biochemicals Recent Developments
Table 169. Hisun Pharmaceutical Basic Information
Table 170. Hisun Pharmaceutical Neurodegenerative Disease Product Overview
Table 171. Hisun Pharmaceutical Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 172. Hisun Pharmaceutical Business Overview
Table 173. Hisun Pharmaceutical Recent Developments
Table 174. Luye Pharma Basic Information
Table 175. Luye Pharma Neurodegenerative Disease Product Overview
Table 176. Luye Pharma Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 177. Luye Pharma Business Overview
Table 178. Luye Pharma Recent Developments
Table 179. Ark Pharmaceutical Basic Information
Table 180. Ark Pharmaceutical Neurodegenerative Disease Product Overview
Table 181. Ark Pharmaceutical Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 182. Ark Pharmaceutical Business Overview
Table 183. Ark Pharmaceutical Recent Developments
Table 184. Kanghong Pharmaceutical Basic Information
Table 185. Kanghong Pharmaceutical Neurodegenerative Disease Product Overview
Table 186. Kanghong Pharmaceutical Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 187. Kanghong Pharmaceutical Business Overview
Table 188. Kanghong Pharmaceutical Recent Developments
Table 189. Huahai Pharmaceutical Basic Information
Table 190. Huahai Pharmaceutical Neurodegenerative Disease Product Overview
Table 191. Huahai Pharmaceutical Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 192. Huahai Pharmaceutical Business Overview
Table 193. Huahai Pharmaceutical Recent Developments
Table 194. BORA PHARMACEUTICALS Basic Information
Table 195. BORA PHARMACEUTICALS Neurodegenerative Disease Product Overview
Table 196. BORA PHARMACEUTICALS Neurodegenerative Disease Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 197. BORA PHARMACEUTICALS Business Overview
Table 198. BORA PHARMACEUTICALS Recent Developments
List of Figures
Figure 1. Product Picture of Neurodegenerative Disease
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neurodegenerative Disease Market Size (M USD), 2024-2033
Figure 5. Global Neurodegenerative Disease Market Size (M USD) (2020-2033)
Figure 6. Global Neurodegenerative Disease Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neurodegenerative Disease Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Neurodegenerative Disease Product Life Cycle
Figure 13. Neurodegenerative Disease Sales Share by Manufacturers in 2024
Figure 14. Global Neurodegenerative Disease Revenue Share by Manufacturers in 2024
Figure 15. Neurodegenerative Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Neurodegenerative Disease Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Neurodegenerative Disease Revenue in 2024
Figure 18. Industry Chain Map of Neurodegenerative Disease
Figure 19. Global Neurodegenerative Disease Market PEST Analysis
Figure 20. Global Neurodegenerative Disease Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Neurodegenerative Disease Market Size by Region
Figure 27. Global Neurodegenerative Disease Market Size Market Share by Region (2020-2033)
Figure 28. Global Neurodegenerative Disease Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Neurodegenerative Disease Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Neurodegenerative Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Neurodegenerative Disease Market Size (M USD) by Country
Figure 33. USA Neurodegenerative Disease Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Neurodegenerative Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Neurodegenerative Disease Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Neurodegenerative Disease Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Neurodegenerative Disease Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Neurodegenerative Disease Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Neurodegenerative Disease Market Size (M USD)by Type
Figure 40. North America Neurodegenerative Disease Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Neurodegenerative Disease Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Neurodegenerative Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Neurodegenerative Disease Market Size (M USD) by Country
Figure 45. Germany Neurodegenerative Disease Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Neurodegenerative Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Neurodegenerative Disease Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Neurodegenerative Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Neurodegenerative Disease Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Neurodegenerative Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Neurodegenerative Disease Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Neurodegenerative Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Neurodegenerative Disease Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Neurodegenerative Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Neurodegenerative Disease Market Size (M USD) by Type
Figure 56. Europe Neurodegenerative Disease Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Neurodegenerative Disease Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Neurodegenerative Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Neurodegenerative Disease Market Size (M USD) by Country
Figure 61. China Neurodegenerative Disease Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Neurodegenerative Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Neurodegenerative Disease Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Neurodegenerative Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Neurodegenerative Disease Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Neurodegenerative Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Neurodegenerative Disease Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Neurodegenerative Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Neurodegenerative Disease Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Neurodegenerative Disease Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Neurodegenerative Disease Market Size (M USD) by Type
Figure 72. Asia-Pacific Neurodegenerative Disease Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Neurodegenerative Disease Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Neurodegenerative Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Neurodegenerative Disease Market Size (M USD) by Country
Figure 77. Brazil Neurodegenerative Disease Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Neurodegenerative Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Neurodegenerative Disease Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Neurodegenerative Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Neurodegenerative Disease Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Neurodegenerative Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Neurodegenerative Disease Market Size (M USD) by Type
Figure 84. South America Neurodegenerative Disease Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Neurodegenerative Disease Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Neurodegenerative Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Neurodegenerative Disease Market Size (M USD) by Country
Figure 89. Saudi Arabia Neurodegenerative Disease Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Neurodegenerative Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Neurodegenerative Disease Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Neurodegenerative Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Neurodegenerative Disease Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Neurodegenerative Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Neurodegenerative Disease Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Neurodegenerative Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Neurodegenerative Disease Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Neurodegenerative Disease Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Neurodegenerative Disease Market Size (M USD) by Type
Figure 100. Middle East and Africa Neurodegenerative Disease Market Size (M USD) by Application
Figure 101. Global Neurodegenerative Disease Production Market Share by Region (2020-2025)
Figure 102. North America Neurodegenerative Disease Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Neurodegenerative Disease Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Neurodegenerative Disease Production (K MT) Growth Rate (2020-2025)
Figure 105. China Neurodegenerative Disease Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Neurodegenerative Disease Market Size by Type (M USD)
Figure 108. Sales Market Share of Neurodegenerative Disease by Type (2020-2033)
Figure 109. Sales Market Share of Neurodegenerative Disease by Type in 2024
Figure 110. Market Size Share of Neurodegenerative Disease by Type (2020-2033)
Figure 111. Market Size Share of Neurodegenerative Disease by Type in 2024
Figure 112. Global Neurodegenerative Disease Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Neurodegenerative Disease Market Size by Application(M USD)
Figure 115. Global Neurodegenerative Disease Market Share by Application
Figure 116. Global Neurodegenerative Disease Sales Market Share by Application (2020-2033)
Figure 117. Global Neurodegenerative Disease Sales Market Share by Application in 2024
Figure 118. Global Neurodegenerative Disease Market Share by Application (2020-2033)
Figure 119. Global Neurodegenerative Disease Market Share by Application in 2024
Figure 120. Global Neurodegenerative Disease Sales Growth Rate by Application (2020-2033)